Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Krystal Biotech, Inc. (KRYS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| ROSSI DINO A (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $117.4, valued at
$798.3k
|
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $117.4, valued at
$798.3k
|
|
| 07/03/2023 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $117.4, valued at
$798.3k
|
|
| 06/09/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 4,604 shares
@ $127.9578, valued at
$589.1k
Sold 1,073 shares
@ $129.0218, valued at
$138.4k
Sold 5,388 shares
@ $128.7335, valued at
$693.6k
Sold 5,000 shares
@ $127.958, valued at
$639.8k
Sold 10,000 shares
@ $127.9584, valued at
$1.3M
Sold 5,000 shares
@ $127.8612, valued at
$639.3k
Sold 3,935 shares
@ $129.2943, valued at
$508.8k
Sold 5,000 shares
@ $128.8375, valued at
$644.2k
Sold 10,000 shares
@ $128.5262, valued at
$1.3M
|
|
| 06/09/2023 |
4
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 5,261 shares
@ $128.1045, valued at
$674k
Sold 6,906 shares
@ $128.9441, valued at
$890.5k
Sold 333 shares
@ $129.6972, valued at
$43.2k
Exercised 12,500 options to buy
@ $63.55, valued at
$794.4k
|
|
| 06/02/2023 |
4
| Krishnan Suma (President, R&D) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 20,143 shares
@ $115.9757, valued at
$2.3M
Sold 4,557 shares
@ $116.8624, valued at
$532.5k
Sold 300 shares
@ $117.5733, valued at
$35.3k
Sold 18,884 shares
@ $115.995, valued at
$2.2M
Sold 5,716 shares
@ $116.9498, valued at
$668.5k
Sold 400 shares
@ $117.605, valued at
$47k
|
|
| 06/02/2023 |
4
| Krishnan Krish S (President and CEO) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 18,884 shares
@ $115.995, valued at
$2.2M
Sold 5,716 shares
@ $116.9498, valued at
$668.5k
Sold 400 shares
@ $117.605, valued at
$47k
Sold 20,143 shares
@ $115.9757, valued at
$2.3M
Sold 4,557 shares
@ $116.8624, valued at
$532.5k
Sold 300 shares
@ $117.5733, valued at
$35.3k
|
|
| 05/23/2023 |
4
| Romano Kathryn (Chief Accounting Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 12,500 shares
@ $95.05, valued at
$1.2M
Sold 12,500 shares
@ $95.0449, valued at
$1.2M
Sold 3,428 shares
@ $95.0808, valued at
$325.9k
Sold 2,521 shares
@ $105.8036, valued at
$266.7k
Sold 2,570 shares
@ $106.8087, valued at
$274.5k
Sold 1,300 shares
@ $107.8777, valued at
$140.2k
Sold 2,955 shares
@ $109.1719, valued at
$322.6k
Sold 3,154 shares
@ $109.9933, valued at
$346.9k
Sold 12,500 shares
@ $110, valued at
$1.4M
Exercised 12,500 options to buy
@ $52.26, valued at
$653.3k
Exercised 12,500 options to buy
@ $52.26, valued at
$653.3k
|
|
| 05/23/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 50,000 shares
@ $95.0237, valued at
$4.8M
|
|
| 05/11/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 17,100 shares
@ $90.7356, valued at
$1.6M
|
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Mazzacco Catherine (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 13,600 options to buy
@ $80.06, valued at
$1.1M
|
|
| 03/09/2023 |
3
| Mazzacco Catherine (Director) has filed a Form 3 on Krystal Biotech, Inc. |
| 03/02/2023 |
4
| ROSSI DINO A (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 40,000 shares
@ $83.2493, valued at
$3.3M
|
|
| 02/28/2023 |
4
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 20,000 options to buy
@ $81.91, valued at
$1.6M
Granted 10,000 rights
@ $0 |
|
| 02/28/2023 |
4
| Romano Kathryn (Chief Accounting Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Paid exercise price by delivering 2,144 shares
@ $78.46, valued at
$168.2k
Granted 20,000 options to buy
@ $81.91, valued at
$1.6M
Granted 10,000 rights
@ $0 |
|
| 02/28/2023 |
4
| Krishnan Suma (President, R&D) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,057 shares
@ $78.46, valued at
$239.9k
Granted 30,000 options to buy
@ $81.91, valued at
$2.5M
Granted 15,000 rights
@ $0 |
|
| 02/28/2023 |
4
| Krishnan Krish S (President and CEO) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Paid exercise price by delivering 4,350 shares
@ $78.46, valued at
$341.3k
Granted 50,000 options to buy
@ $81.91, valued at
$4.1M
Granted 25,000 rights
@ $0 |
|
| 01/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|